Lexicon Pharmaceuticals Inc

-0.08 (-1.64%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)691.64M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.01 Million
Adjusted EPS-$0.16
See more estimates
10-Day MA$4.73
50-Day MA$4.76
200-Day MA$4.15
See more pivots

Lexicon Pharmaceuticals Inc Stock, NASDAQ:LXRX

8800 Technology Forest Place, The Woodlands, Texas 77381-1160
United States of America
Phone: +1.281.863.3000
Number of Employees: 78


Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.